cis-3-Hexenyl isovalerate
Common Name: |
cis-3-Hexenyl isovalerate |
IUPAC Name: |
[(Z)-hex-3-enyl] 3-methylbutanoate |
Molecular Formula: |
C11H20O2 |
SMILES: |
CCC=CCCOC(=O)CC(C)C |
Inchi: |
1S/C11H20O2/c1-4-5-6-7-8-13-11(12)9-10(2)3/h5-6,10H,4,7-9H2,1-3H3/b6-5- |
Inchi Key: |
AIQLNKITFBJPFO-WAYWQWQTSA-N |
Cas No: |
35154-45-1 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
184.28 |
Mass (g/mol) |
184.146 |
Molar Refractivity |
55.80 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
7 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
13 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
199.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.061 |
Vapor Density (Air =1) |
6.3 |
Fraction Csp3 |
0.73 |
LogP |
2.932 |
iLOGP |
2.97 |
XLOGP3 |
3.15 |
WLOGP |
2.93 |
MLOGP |
2.76 |
ESOL Log S |
-2.51 |
ESOL Solubility (mg/ml) |
0.576 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.37 |
Ali Solubility (mg/ml) |
0.08 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.49 |
Silicos-IT Solubility (mg/ml) |
0.6 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.19 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.038 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.423 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |